870615-45-5

Basic information

• Product Name: [4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-2,3,6,10b-tetraaza-benzo[e]azulen-6-yl]-acetic acid
• Synonyms: [4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-2,3,6,10b-tetraaza-benzo[e]azulen-6-yl]-acetic acid
• CAS NO: 870615-45-5
• Molecular Weight: 463.495
• Mol File: 870615-45-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: [4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-2,3,6,10b-tetraaza-benzo[e]azulen-6-yl]-acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: [4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-2,3,6,10b-tetraaza-benzo[e]azulen-6-yl]-acetic acid(870615-45-5)
• EPA Substance Registry System: [4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-2,3,6,10b-tetraaza-benzo[e]azulen-6-yl]-acetic acid(870615-45-5)

Safety Data

• Hazardous Substances Data: 870615-45-5(Hazardous Substances Data)

Upstream product

• 137731-25-0 1-phenyl-4H-<1,2,4>-triazolo<4,3-a><1,5>benzodiazepin-5(6H)-one 

Downstream Products

• 1228934-93-7 6-{2-[2-(cyclohexylmethyl)piperidin-1-yl]-2-oxoethyl}-4-(1H-indol-3-ylmethyl)-1-phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5(6H)-one 
• 1373952-55-6 C₃₇H₃₂N₆O₂ 
• 1373952-54-5 C₃₇H₃₃N₇O₂ 
• 1228935-00-9 6-[2-(2-benzylpiperidin-1-yl)-2-oxoethyl]-4-(1H-indol-3-ylmethyl)-1-phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5(6H)-one 
• 1228934-80-2 4-(1H-indol-3-ylmethyl)-6-{2-[2-(2-methoxyethyl)piperidin-1-yl]-2-oxoethyl}-1-phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5(6H)-one 
• 1228934-91-5 4-(1H-indol-3-ylmethyl)-6-{2-oxo-2-[2-(pyridin-2-ylmethyl)piperidin-1-yl]ethyl}-1-phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5(6H)-one 
• 1228934-85-7 4-(1H-indol-3-ylmethyl)-6-{2-oxo-2-[2-(pyridin-4-ylmethyl)piperidin-1-yl]ethyl}-1-phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5(6H)-one 
• 1228934-82-4 4-(1H-indol-3-ylmethyl)-6-[2-oxo-2-(2-phenylpiperidin-1-yl)ethyl]-1-phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5(6H)-one 
• 1228934-81-3 6-[2-(2-ethylpiperidin-1-yl)-2-oxoethyl]-4-(1H-indol-3-ylmethyl)-1-phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5(6H)-one 
• 1228934-87-9 4-(1H-indol-3-ylmethyl)-6-[2-(2-isopropylpiperidin-1-yl)-2-oxoethyl]-1-phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5(6H)-one 
• 1373952-52-3 C₃₈H₃₄N₆O₂ 
• 1228934-89-1 4-(1H-indol-3-ylmethyl)-6-{2-[2-(3-methoxybenzyl)piperidin-1-yl]-2-oxoethyl}-1phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5(6H)-one 
• 1228934-98-2 4-(1H-indol-3-ylmethyl)-6-{2-[2-(4-methoxyphenyl)piperidin-1-yl]-2-oxoethyl}-1-phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5(6H)-one 
• 1228934-83-5 4-(1H-indol-3-ylmethyl)-6-{2-oxo-2-[(2R)-2-pyridin-2-ylpiperidin-1-yl]ethyl}-1-phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5(6H)-one 

Relevant articles and documents

Discovery of new piperidine amide triazolobenzodiazepinones as intestinal-selective CCK1 receptor agonists

New cholecystokinin-1 receptor (CCK1R) agonist 'triggers' were identified using iterative library synthesis. Structural activity relationship studies led to the discovery of compound 10e, a potent CCK1R agonist that demonstrated robust weight loss in a di